The Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome
Nutrients · 2024
DOI: 10.3390/nu16233977 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, 2024. Verfasst von Lucilla Ricottini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sinergheia Clinical Center, 00192 Rome, Italy. Hauptthemen laut MEDLINE: Dietary Supplements, Metabolic Syndrome, Overweight. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The aim of the present study was to evaluate the effectiveness and safety of a nutraceutical combination given to insulin-resistant overweight patients with altered lipid profiles. To this end, an observational study was designed in which 74 individuals (50 females and 24 males) underwent an observational period of 3 months.
Methods
During this time, a specific nutraceutical combination containing myo-inositol, glycine, Coprinus comatus, α-lipoic acid, phlorizin, zinc, vitamin B6, and chromium picolinate was administered. Patients were asked not to modify their lifestyles so that no variable that might interfere with results was introduced.
Results
After the 3-month period, the obtained data revealed that insulin levels significantly decreased with respect to the baseline, while glucose levels exhibited a trend towards lower concentrations, which was not significant. In addition, HOMA-IR index, body weight, BMI, and abdominal circumference values all decreased significantly. Regarding lipid profiles, the data obtained before and after the 3-month period showed statistically significant decreases in concentrations of total cholesterol, LDL cholesterol, and triglyceride, as well as a small but statistically significant concomitant increase in HDL cholesterol.
Conclusions
Thus, on the basis of these data, it may be stated that the specific nutraceutical combination used in the present study significantly ameliorated a number of metabolic parameters without measurable side effects. The efficacy and safety of the product were, therefore, confirmed in our group of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sinergheia Clinical Center, 00192 Rome, Italy.
- Department of Experimental Medicine, University "Sapienza", 00161 Rome, Italy.
- De Mattia Center for Nutrition and Obesity, 70124 Bari, Italy.
- Delle Noci Multy Specialty Center, 70124 Bari, Italy.
- Villa Brasini Medical Center, 20100 Milan, Italy.
ORCID-Profile: Maurizio Nordio
Zitieren
APA
Ricottini, L., Basciani, S., Spizzichini, M. L., de Mattia, D., Coniglio-Iannuzzi Delle Noci, M., Sorrentino, S., & Nordio, M. (2024). The Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome. Nutrients. https://doi.org/10.3390/nu16233977
Vancouver
Ricottini L, Basciani S, Spizzichini ML, de Mattia D, Coniglio-Iannuzzi Delle Noci M, Sorrentino S, et al. The Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome. Nutrients. 2024. doi:10.3390/nu16233977
BibTeX
@article{Ricottini2024,
author = {Ricottini, Lucilla and Basciani, Sabrina and Spizzichini, Maria Letizia and de Mattia, Domenico and Coniglio-Iannuzzi Delle Noci, Manuela and Sorrentino, Sasha and Nordio, Maurizio},
title = {The Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16233977}
}
EUVIMED